Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Apr 5, 2007 at 10:36 PM EDT

Thursday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology GENETIC TECH SPON [GENE] +48.22% DENDREON CORP [DNDN] +19.69% CORCEPT THERAPEUTICS [CORT] +15.70% ANTIGENICS INC…

Douglas A. McIntyre | Apr 5, 2007 at 3:11 AM EDT

Wednesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology IDM PHARMA INC [IDMI] +45.33% NANOGEN INC [NGEN] +30.95% ENCYSIVE PHARMA [ENCY] +14.89% CARDIOVASCULAR BIOTH…

Douglas A. McIntyre | Apr 4, 2007 at 5:45 PM EDT

Jim Cramer on Dendreon (DNDN)

Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon…

Douglas A. McIntyre | Apr 4, 2007 at 8:04 AM EDT

Medarex Stock Options Activity Resembles Dendreon’s Trading

Stock Tickers: MEDX, DNDN When traders made bets and saw a move of more than 200% at one point onFriday…

Douglas A. McIntyre | Apr 4, 2007 at 3:05 AM EDT

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 3, 2007 at 4:44 PM EDT

Biotech Implosion: ICAgen (ICGN)

ICAgen’s (ICGN-NASDAQ) stock is being crushed in after-hours trading, although the trading volume is very light. Shares are down 37%…

Douglas A. McIntyre | Apr 3, 2007 at 3:05 AM EDT

Monday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology STEMCELLS INC [STEM] +18.25% NOVAVAX INC [NVAX] +17.76% POLYMEDIX INC [PYMX.OB] +15.79% IDM PHARMA INC…

Douglas A. McIntyre | Apr 3, 2007 at 3:03 AM EDT

Stem Cell Stocks Gain On British Study, Geron Gives Some Back

by H.S. AyoubBioHealth Investor Scientists in Britain announced that a new heart-like muscle mass, complete with blood vessels and various…

Douglas A. McIntyre | Apr 2, 2007 at 2:59 AM EDT

Weekly Top Biotech and Medical Business Articles

by H.S. AyoubBioHealth Investor.com The following articles were the most popular at BioHealth Investor for the week of March 24…

Douglas A. McIntyre | Apr 1, 2007 at 12:01 PM EDT

Barron’s Alzheimer’s Article Only Scratches the Surface

Stock Tickers: WYE, NRMX, ELN, NVS, PFE, LLY, JNJ, AZN, TRGT, SNH, SRZ, BKD, ALC, HCR, ESC, MYGN, FRX, NYMX,…

Douglas A. McIntyre | Mar 30, 2007 at 8:24 AM EDT

Other Biotech Stocks Chasing Dendreon Pre-Market

This shouldn’t be any shocker now, but the small-cap biotech stocks are getting attention this morning. Of particular interest are…

Douglas A. McIntyre | Mar 30, 2007 at 6:23 AM EDT

Dendreon Massive Pre-Market

Dendreon (DNDN-NASDAQ) won big yesterday after receiving panel backing from the FDA for Provenge for the treatment of advanced prostate…

Douglas A. McIntyre | Mar 30, 2007 at 3:10 AM EDT

The Rising Cost of Healthcare Taken To Another Extreme

By Chad Brand of Peridot Capitalist LOS ANGELES, March 26 (Reuters) – Shares of Alexion Pharmaceuticals Inc. (ALXN) rose more…

Douglas A. McIntyre | Mar 30, 2007 at 3:04 AM EDT

ART Is Not A Luxury!

by H.S. AyoubBioHealth Investor.com One of the most over-used arguments against assisted reproductive technology (ART) is that couples do not…

Douglas A. McIntyre | Mar 29, 2007 at 7:49 PM EDT

Dendreon Conference Call Transcript Summary (MAR 29, 2007)

Dendreon (DNDN-NASDAQ) spoke on a planned conference call this evening that was moved to 6:30 PM EST rather than the…

1 … 374 375 376 377 378 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Thursday’s Top Biotech & Medical Stocks

Wednesday’s Top Biotech & Medical Stocks

Jim Cramer on Dendreon (DNDN)

Medarex Stock Options Activity Resembles Dendreon’s Trading

Tuesday’s Top Biotech & Medical Stocks

Biotech Implosion: ICAgen (ICGN)

Monday’s Top Biotech & Medical Stocks

Stem Cell Stocks Gain On British Study, Geron Gives Some Back

Weekly Top Biotech and Medical Business Articles

Barron’s Alzheimer’s Article Only Scratches the Surface

Other Biotech Stocks Chasing Dendreon Pre-Market

Dendreon Massive Pre-Market

The Rising Cost of Healthcare Taken To Another Extreme

ART Is Not A Luxury!

Dendreon Conference Call Transcript Summary (MAR 29, 2007)

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Health and Healthcare Articles

All Health and Healthcare Articles

Thursday’s Top Biotech & Medical Stocks

Wednesday’s Top Biotech & Medical Stocks

Jim Cramer on Dendreon (DNDN)

Medarex Stock Options Activity Resembles Dendreon’s Trading

Tuesday’s Top Biotech & Medical Stocks

Biotech Implosion: ICAgen (ICGN)

Monday’s Top Biotech & Medical Stocks

Stem Cell Stocks Gain On British Study, Geron Gives Some Back

Weekly Top Biotech and Medical Business Articles

Barron’s Alzheimer’s Article Only Scratches the Surface

Other Biotech Stocks Chasing Dendreon Pre-Market

Dendreon Massive Pre-Market

The Rising Cost of Healthcare Taken To Another Extreme

ART Is Not A Luxury!

Dendreon Conference Call Transcript Summary (MAR 29, 2007)

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Featured Reads

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62